Reference library Reference values and primary sourcesSchematics, not to scale
Blood and lymph
How blood and lymph carry what the body absorbs: the two circuits, what blood is made of, the plasma proteins that bind and transport compounds, clotting and vitamin K, and the lymphatic route that lets fat-soluble compounds reach the blood without passing the liver first.
5.3 Lreference total blood volume of the adult man (3.9 L for the adult woman)
126 daysreference life span of a red blood cell in adults (range 112–154)
≈500×portal blood flow relative to intestinal lymph flow, which is why most absorbed molecules enter the blood
0.2%share of the adult body's lymphocytes that are in the blood at any one time
ICRP Publication 89 (2002), §7.2, §7.4 and §7.8.2; Trevaskis NL, Charman WN, Porter CJH. Adv Drug Deliv Rev 2008;60:702–716.
Status. Education, not medical advice. EUTECNIQ is in formation and has no laboratory, studies or clinical data. Figures restate published reference values and study results; schematics are drawn for this page and are not to scale.
Blood passes the lungs and the body in series, and the organs in parallel
The right ventricle pumps blood through the lungs to the left atrium; the left ventricle pumps it into the aorta and through every systemic capillary bed back to the right atrium. Blood from the gut, spleen and pancreas passes the liver before it rejoins the venous return. The adult reference cardiac output at rest is 6.5 L/min for men and 5.9 L/min for women.
One heart, two pumps: the right side feeds the lungs, the left side feeds every other organSchematic, not to scale
Path and valves: OpenStax Anatomy and Physiology 2e, §19.1. Organ flows: ICRP Publication 89 (2002), §7.7.2, adult male, percent of cardiac output. Lymph return: OpenStax §21.1; Ilahi et al., StatPearls, Thoracic Duct (2023).Text version of the drawing: the order of passage
Right atriumReceives the superior and inferior venae cavae and the coronary sinus, which drains the heart muscle.
Right ventricleFilled through the tricuspid valve; pumps oxygen-poor blood through the pulmonary semilunar valve into the pulmonary trunk and arteries.
LungsIn the pulmonary capillaries carbon dioxide leaves the blood and oxygen enters.
Left atrium and left ventricleThe pulmonary veins return blood to the left atrium; the mitral valve opens to the left ventricle, which pumps through the aortic semilunar valve into the aorta.
Systemic capillary bedsOrgans are supplied in parallel: brain 12%, kidneys 19%, skeletal muscle 17%, skin 5%, adipose tissue 5%, coronary 4% of cardiac output (adult male). Gut, spleen and pancreas drain through the portal vein to the liver, which receives 25.5% of cardiac output in all, 6.5% of it by the hepatic artery.
Venous returnVeins and the venae cavae return blood to the right atrium. Lymph enters the veins near the heart.
The kidneys hold 2% of the blood but receive 19% of the flow; skeletal muscle holds 14% and receives 17%ICRP Publication 89 reference values
ICRP Publication 89 (2002), §7.7.2, reference values for regional blood volumes and blood flow rates, adult male (adopted from Williams and Leggett 1989; Leggett and Williams 1991, 1995). Female values differ for adipose tissue (8.5% of volume and flow), skeletal muscle (10.5% and 12%) and some others.Show data: blood content and blood flow by organ, adult male and female
Blood content as percent of total blood volume and blood flow as percent of cardiac output, ICRP reference adult male and female
Organ or tissue
Blood content, % of total (male / female)
Blood flow, % of cardiac output (male / female)
Liver
10 / 10
25.5 / 27.0 total (6.5 / 6.5 arterial)
Kidneys
2.0 / 2.0
19 / 17
Skeletal muscle
14 / 10.5
17 / 12
Brain
1.2 / 1.2
12 / 12
Small intestine
3.8 / 3.8
10 / 11
Skeleton (red marrow 4.0 / 4.0 of content, 3.0 / 3.0 of flow)
7.0 / 7.0
5.0 / 5.0
Adipose tissue
5.0 / 8.5
5.0 / 8.5
Skin
3.0 / 3.0
5.0 / 5.0
Coronary tissue
1.0 / 1.0
4.0 / 5.0
Large intestine
2.2 / 2.2
4.0 / 5.0
Spleen
1.4 / 1.4
3.0 / 3.0
Bronchial tissue
2.0 / 2.0
2.5 / 2.5
Lymph nodes
0.2 / 0.2
1.7 / 1.7
Thyroid
0.06 / 0.06
1.5 / 1.5
Heart chambers (right + left)
9.0 / 9.0
—
Pulmonary circulation
10.5 / 10.5
— (all of the cardiac output)
Aorta and large arteries; large veins
6.0; 18 (both sexes)
—
ICRP Publication 89 (2002), §7.7.2. Rows not shown in the chart: stomach and esophagus 1.0 / 1.0 and 1.0 / 1.0; pancreas 0.6 and 1.0; adrenals 0.06 and 0.3; gonads; urinary bladder; all other tissues.
About 60% of the blood is in the systemic veins and only 5% in the systemic capillaries at any momentICRP Publication 89 reference values
ICRP Publication 89 (2002), §7.6, distribution of blood in the vascular system of a recumbent adult man (from Brobeck 1979, Rothe 1983, Leggett and Williams 1991). Systemic veins: small veins 41.5% + large veins 18% = 59.5%, computed.Show data: blood volume and cardiac output by age, and the vascular distribution
ICRP reference total blood volume and resting cardiac output by age and sex
Age
Total blood volume, L (male / female)
Cardiac output, L/min (male / female)
Newborn
0.27 / 0.27
0.6 / 0.6
1 year
0.5 / 0.5
1.2 / 1.2
5 years
1.4 / 1.4
3.4 / 3.4
10 years
2.4 / 2.4
5.0 / 5.0
15 years
4.5 / 3.3
6.1 / 6.1
Adult
5.3 / 3.9
6.5 / 5.9
ICRP Publication 89 (2002), §7.4 (18 studies of healthy subjects resting recumbent) and §7.5 (trimmed means of more than 50 studies). Vascular distribution, percent of total blood volume: heart chambers 9; pulmonary 10.5 (arteries 3, capillaries 2, veins 5.5); systemic 80.5 (aorta and large arteries 6, small arteries 10, capillaries 5, small veins 41.5, large veins 18).
Organ volumes and flows in physiologically based models come from tables like these; the model structure and the hepatic first pass are covered on ADME, PK and PBPK.
Composition
Red cells are about 43% of a man's blood and 38% of a woman's; plasma is the rest
Blood volume is essentially plasma plus red cells; white cells and platelets add little volume. Plasma is mostly water, with proteins making up nearly all of the rest. Reference values differ between sources and laboratories, so each number below names its source.
Of 5,300 mL of blood in the reference man, 2,300 mL is red cells; neutrophils and lymphocytes make up most white cellsICRP Publication 89 reference values
ICRP Publication 89 (2002), §7.3 (red cell and plasma volumes, based on red cells at about 43% (42–52%) of blood volume in men and 38% (37–48%) in women) and §7.2.3 (typical leukocyte values summarized from ICRP Publication 23, 1975).
Reference values for blood and plasma from two sources, showing how values differ between sources
Measure
ICRP Publication 89 (typical values)
Other source
Red cells, share of blood volume
About 43% (42–52%) men; 38% (37–48%) women
About 47% men, 41% women; “about 45 percent” in normal blood (OpenStax §18.1)
150,000 to 450,000/µL, “although reference ranges may vary among laboratories” (StatPearls, Physiology, Platelet)
Plasma water
94%
About 92%; proteins about 7% of plasma volume; other solutes about 1% (OpenStax §18.1)
Blood pH
7.4 (red cells 7.2)
Average 7.4; 7.35 to 7.45 in a healthy person (OpenStax §18.1)
Plasma glucose
95 mg/100 mL
—
Specific gravity
Blood 1.06; plasma 1.027; red cells 1.09
—
ICRP Publication 89 (2002), §7.2–7.3. 1 mm³ = 1 µL. OpenStax Anatomy and Physiology 2e, §18.1, §18.3, §18.4; Denault D, Launico MV. Physiology, Platelet. StatPearls, updated September 14, 2026. A clinical laboratory reports its own reference intervals; these tables are for orientation only.
Show data: leukocyte types (ICRP Publication 89, §7.2.3)
Typical percentage of each leukocyte type in blood, mean and standard deviation
Leukocyte type
% of leukocytes (mean ± SD)
Segmented neutrophils
47 ± 9
Lymphocytes
35 ± 7
Juvenile neutrophils
8 ± 5
Monocytes
6.5 ± 2
Eosinophils
3 ± 2
Basophils
0.6 ± 0.5
Life spans and production
Life spans of blood cells as stated by the named sources
Cell
Life span in the circulation
Source
Red blood cell
126 (112–154) days in adults; “up to 120 days”
ICRP Publication 89, §7.2.2; OpenStax §18.3
Platelet
7 to 10 days, then cleared by the spleen and liver; “about 10 days”
StatPearls, Physiology, Platelet; OpenStax §18.4
Granular leukocytes
Hours to days
OpenStax §18.4
Memory B and T cells
Many years
OpenStax §18.4
Adults produce about 3.5 × 10⁹ red cells per kilogram of body weight per day (men) and 2.63 × 10⁹ (women). For the 73 kg reference man that is about 2.6 × 10¹¹ per day, or about 3 million per second, consistent with the textbook figure of more than 2 million per second.
ICRP Publication 89 (2002), §7.2.2 and Table 2.9 (73 kg); OpenStax §18.3. Daily and per-second figures computed on this page.
Hematopoiesis
All blood cells come from hematopoietic stem cells. After birth most hematopoiesis occurs in red bone marrow; in adults it is largely restricted to the cranial and pelvic bones, the vertebrae, the sternum and the proximal ends of the femur and humerus. The reference adult man has 1,170 g of active marrow.
Myeloid progenitors give platelets, red cells, granulocytes and monocytes; lymphoid progenitors give B, T and NK cellsSchematic, classical model
Chapman J, Zhang Y. Histology, Hematopoiesis. StatPearls, updated May 1, 2023; OpenStax §18.2 (sites, thrombopoietin from liver and kidneys); Schoener B, Borger J. Erythropoietin Stimulating Agents. StatPearls, updated July 14, 2024 (erythropoietin from peritubular cells of the renal cortex, stimulates red cell production). Active marrow: ICRP Publication 89, Table 2.8.Text version of the drawing
Hematopoietic stem cells self-renew or become multipotent progenitors, which cannot self-renew. These split into common myeloid progenitors, which give megakaryocytes (shedding platelets into marrow sinuses), erythrocytes (proerythroblast to reticulocyte, up to 5 days) and, through the myeloblast lineage, neutrophils, eosinophils, basophils and monocytes; and common lymphoid progenitors, which give B cells, T cells and natural killer cells. B cells develop in red marrow and plasma cells derived from them make immunoglobulins; T cells mature in the thymus. Signals include erythropoietin, thrombopoietin, colony-stimulating factors and interleukins. Lineage-tracing studies have revised this branching picture toward a more continuous one.
Plasma proteins
The liver makes most plasma proteins; plasma cells make the immunoglobulins
Albumin is about 54% of plasma protein, globulins about 38% and fibrinogen about 7%. Many of these proteins are carriers: they hold hormones, vitamins, metals and drugs in the blood and release them in equilibrium. Several change during inflammation, which changes how much of a bound compound is free.
Plasma proteins: where they are made, what they do, what they bind, and their direction as acute-phase proteins
Protein (gene)
Made mainly in
Function
Binds or carries
In inflammation
Albumin (ALB)
Liver hepatocytes, 10–15 g/day
Main regulator of colloid osmotic pressure
Water, Ca²⁺, Na⁺, K⁺, fatty acids (up to 9), hormones, bilirubin, drugs; about 80% of plasma zinc; drugs at Sudlow site I (warfarin) and site II (diazepam, ibuprofen)
Falls (negative)
Alpha-1-acid glycoprotein (ORM1)
Liver
Transport protein; modulates immune activity in the acute phase
Ligands inside its β-barrel; synthetic drugs; basic drugs bind predominantly to it
Rises (positive)
Transferrin (TF)
Liver
Carries iron from absorption and heme breakdown to storage and use
Two Fe³⁺ ions, each with an anion, usually bicarbonate
Falls (negative)
Ferritin (FTL, FTH1)
Liver (heavy chain)
Stores iron in a soluble, non-toxic, readily available form
Iron, deposited as ferric hydroxides
Rises (positive)
Ceruloplasmin (CP)
Liver
Ferroxidase: oxidizes Fe²⁺ to Fe³⁺ for loading onto transferrin
6–7 copper atoms per molecule
Listed among acute-phase proteins; direction not stated
Haptoglobin (HP)
Liver
Captures free hemoglobin so the liver recycles heme iron and the kidney is protected
Hemoglobin
Rises (positive); falls in hemolysis
Sex hormone–binding globulin (SHBG)
Liver; testis
Androgen transport; regulates the plasma clearance rate of steroid hormones
Dihydrotestosterone, testosterone, 17β-estradiol; one steroid per dimer
—
Thyroxine-binding globulin (SERPINA7)
Liver
Major thyroid hormone transport protein in serum
Thyroid hormones
—
Transthyretin (TTR)
Choroid plexus; also liver and retinal pigment epithelium
Thyroid hormone binding; probably carries thyroxine from blood to brain
Thyroxine
Falls (negative)
Vitamin D–binding protein (GC)
Liver
Vitamin D transport and storage; scavenges extracellular G-actin
Vitamin D
—
Retinol-binding protein 4 (RBP4)
Liver
Delivers retinol from liver stores to tissues, handing it to the STRA6 receptor
All-trans retinol
Falls (negative)
Immunoglobulins (IGHG1 and others)
Plasma cells, derived from B cells
Antibodies; about 20% of plasma protein
Specific antigens
—
Complement C3 (C3)
Liver
Cleaved to C3b, which coats pathogens for removal, and C3a, a local inflammatory mediator
C3b binds covalently to pathogen surfaces
—
Fibrinogen (FGA, FGB, FGG)
Liver
Converted by thrombin to fibrin, the main structural part of a clot; 200–400 mg/dL; half-life 3–4 days
—
Rises (positive)
Function, ligands and tissue: UniProt entries P02768, P02763, P02787, P02792, P02794, P00450, P00738, P04278, P05543, P02766, P02774, P02753, P01857, P01024, P02671 (retrieved October 30, 2026). Albumin synthesis, Sudlow sites and fatty acids: Moman RN, et al. Physiology, Albumin. StatPearls, updated January 31, 2026. Basic drugs and alpha-1-acid glycoprotein: Bisht S, et al. StatPearls, updated March 22, 2026. Acute-phase direction: Gulhar R, et al. Physiology, Acute Phase Reactants. StatPearls, 2023. Immunoglobulins: Patel P, et al. StatPearls, 2023; fibrinogen: Kaur J, et al. StatPearls, 2025. Plasma protein fractions: OpenStax §18.1.
Twenty of 22 plasma-protein genes are expressed most in the liver; transthyretin peaks in the choroid plexusHuman Protein Atlas data
Human Protein Atlas, consensus RNA tissue data (nTPM) and tissue specificity categories, gene pages retrieved October 30, 2026. “Tissue enriched”: at least four-fold higher mRNA level in one tissue than in any other. mRNA level indicates where a protein is made; it is not a plasma concentration.Show data: HPA tissue of highest expression, nTPM and specificity category
Human Protein Atlas RNA tissue specificity for 22 plasma-protein genes
Gene (protein)
Tissue
nTPM
HPA category
TTR (transthyretin)
Choroid plexus
672,504.5
Tissue enriched
ALB (albumin)
Liver
198,523.8
Tissue enriched
HP (haptoglobin)
Liver
55,848.1
Tissue enriched
ORM1 (alpha-1-acid glycoprotein 1)
Liver
42,168.4
Tissue enriched
APOA1 (apolipoprotein A-I)
Liver
20,151.0
Tissue enriched
FGA (fibrinogen alpha chain)
Liver
17,201.5
Tissue enriched
FTL (ferritin light chain)
Liver
14,257.7
Tissue enhanced
RBP4 (retinol-binding protein 4)
Liver
11,054.0
Tissue enriched
IGHG1 (IgG1 heavy chain constant region)
Lymphoid tissue (also urinary bladder 3,756.3)
10,950.9
Group enriched
GC (vitamin D–binding protein)
Liver
7,722.0
Tissue enriched
TF (transferrin)
Liver (also retina 2,256.7)
7,020.0
Group enriched
C3 (complement C3)
Liver
5,062.4
Tissue enriched
CP (ceruloplasmin)
Liver
1,750.2
Tissue enriched
F2 (prothrombin)
Liver
1,138.4
Tissue enriched
APOB (apolipoprotein B)
Liver (also intestine 286.7)
1,114.1
Group enriched
F9 (factor IX)
Liver
659.1
Tissue enriched
PROC (protein C)
Liver
584.1
Tissue enriched
PROS1 (protein S)
Liver (also choroid plexus 133.4)
264.9
Tissue enhanced
SERPINA7 (thyroxine-binding globulin)
Liver
263.9
Tissue enriched
F10 (factor X)
Liver
149.7
Tissue enhanced
F7 (factor VII)
Liver
128.6
Tissue enriched
SHBG (sex hormone–binding globulin)
Liver
59.3
Tissue enriched
Lipoproteins carry fat and fat-soluble compounds
Lipoprotein classes: origin, apolipoproteins, cargo and size where a source states it
Class
Origin
Apolipoproteins
Cargo and properties
Chylomicron
Enterocytes of the small intestine, from dietary lipid
B-48 (one per particle), A-I, A-II, A-IV, C-I, C-II, C-III, E
More than 75% triglyceride, about 2% protein; density below 0.94 g/mL; 75–1,200 nm
VLDL
Liver; MTP is required for its lipidation
B-100, C-I, C-II, C-III, E
Endogenous triglyceride and some cholesterol; 30–80 nm
IDL
Remnant of VLDL after lipoprotein lipase acts
B-100, C-III, E
Cholesterol esters and triglyceride
LDL
Formed from IDL through hepatic lipase
B-100, one per particle, the ligand for the LDL receptor
Cholesterol esters
HDL
Apolipoprotein A-I is made in liver and small intestine
A-I, A-II, C-I, C-II, C-III, D, E
Cholesterol esters; apoA-I promotes cholesterol efflux from tissues to the liver
Lent-Schochet D, Jialal I. Biochemistry, Lipoprotein Metabolism. StatPearls, 2023; Rahmany S, Jialal I. Biochemistry, Chylomicron. StatPearls, 2023; Devaraj S, et al. Biochemistry, Apolipoprotein B. StatPearls, 2023; UniProt P02647 (APOA1), P04114 (APOB). Sizes: Yáñez JA, et al. Adv Drug Deliv Rev 2011;63:923–942. ApoB-48 is formed in the intestine by apoB mRNA editing (APOBEC1).
Protein binding and the unbound fraction
In plasma a compound is in equilibrium between bound and unbound forms. The unbound fraction fu = Cunbound/Ctotal is the part that is pharmacologically active and subject to tissue distribution and elimination. Acidic compounds bind mainly to albumin and basic ones mainly to alpha-1-acid glycoprotein; lipoproteins are a third class of binding protein.
Lower albumin leaves fewer binding sites and raises the unbound fraction of highly albumin-bound drugs. Displacement from a binding site raises the free fraction only transiently, because the extra unbound drug is also cleared faster; warfarin displaced by sulfonamides or NSAIDs is the textbook example. How fu enters hepatic extraction and PBPK models is shown on ADME, PK and PBPK.
Bisht S, Chauhan V, Patel P. Clinical Significance of Volume of Distribution in Pharmacotherapy. StatPearls, updated March 22, 2026; Moman RN, et al. Physiology, Albumin. StatPearls, 2026 (unbound drug “pharmacologically active and subject to tissue distribution and elimination”).
Coagulation
Factors II, VII, IX and X and proteins C and S need vitamin K to be completed, and warfarin blocks its recycling
Hemostasis begins with vessel spasm and a platelet plug; coagulation then builds a fibrin mesh that stabilizes the plug. The clotting factors circulate as inactive zymogens and activate each other in sequence. The liver makes most of them, and it needs vitamin K to finish factors II, VII, IX and X and the regulators protein C and protein S. Protein Z, the cofactor that lets protein Z–dependent protease inhibitor inactivate factor Xa, is also vitamin K–dependent.
Both pathways converge on factor X; thrombin then turns fibrinogen into fibrinSchematic
Chaudhry R, Killeen RB, Babiker HM. Physiology, Coagulation Pathways. StatPearls, updated June 2, 2025 (pathways; protein Z); OpenStax §18.5 (tissue factor pathway inhibitor, antithrombin, protein C, plasmin); UniProt P00734, P08709, P00740, P00742, P04070, P07225. Vitamin K–dependent factors: Patel S, et al. Warfarin. StatPearls, updated October 5, 2024.Text version of the drawing
Intrinsic pathway: factor XII is activated on exposure to collagen after endothelial damage; XIIa activates XI, XIa activates IX, and IXa with cofactor VIIIa, Ca²⁺ and phospholipid (intrinsic tenase) activates X. Extrinsic pathway: tissue factor (factor III) released after vascular injury forms a complex with VIIa and Ca²⁺ (extrinsic tenase) that activates X. Common pathway: Xa with cofactor Va, Ca²⁺ and phospholipid (prothrombinase) converts prothrombin (II) to thrombin (IIa); thrombin converts fibrinogen (I) to fibrin, and XIIIa cross-links the fibrin into a mesh. Thrombin also activates factor XI, the cofactors V and VIII, and factor XIII. Brakes: activated protein C with protein S inactivates Va and VIIIa; antithrombin opposes thrombin formation and inactivates Xa; tissue factor pathway inhibitor inhibits the extrinsic pathway; plasmin breaks down fibrin. The partial thromboplastin time (PTT) assesses the intrinsic pathway and the prothrombin time (PT) the extrinsic pathway.
Each carboxylation consumes reduced vitamin K; VKORC1 regenerates it, and that is the step warfarin inhibitsSchematic
UniProt P38435 (GGCX, vitamin K-dependent gamma-carboxylase, EC 4.1.1.90) and Q9BQB6 (VKORC1, EC 1.17.4.4), retrieved October 30, 2026; Imbrescia K, Moszczynski Z. Vitamin K. StatPearls, updated July 10, 2023; Patel S, et al. Warfarin. StatPearls, 2024.Text version of the drawing
Vitamin K is reduced to vitamin K hydroquinone by VKORC1; a warfarin-resistant second reductase, FSP1, was identified in 2022 (Mishima E, et al. Nature 2022;608:778–783, doi:10.1038/s41586-022-05022-3). Gamma-glutamyl carboxylase (GGCX) uses the hydroquinone to convert glutamate (Glu) residues of precursor proteins to gamma-carboxyglutamate (Gla), which binds calcium, and in the same active site forms vitamin K 2,3-epoxide. VKORC1 reduces the epoxide back to vitamin K. GGCX substrates include factors II, VII, IX and X, protein C, osteocalcin and matrix Gla protein. Warfarin competitively inhibits VKORC1, so the liver releases clotting factors that lack enough Gla residues.
Platelets
Platelets are 3–4 µm anucleate fragments of bone marrow megakaryocytes; thrombopoietin is their main growth factor. At an injury they adhere to exposed collagen, held by von Willebrand factor, then activate and aggregate into the primary plug that fibrin later stabilizes.
In crossover studies, St John's wort lowered warfarin's effect; ginkgo and ginger did not change it
Warfarin is 99% protein bound and is metabolized mainly by CYP2C9. A supplement can change its effect by supplying vitamin K or by changing its clearance. The human studies below measured both the drug and its effect, the international normalized ratio (INR) of prothrombin time.
St John's wort raised warfarin clearance by about a quarter and lowered INR exposure by about a fifthHuman pharmacokinetic studies
Jiang X, et al. Br J Clin Pharmacol 2004;57:592–599 (St John's wort, 14 days' pretreatment) and 2005;59:425–432 (ginkgo, ginger, 7 days); open-label, randomized three-way crossover studies in 12 healthy men given a single 25 mg dose of warfarin. Mean ratio with 90% confidence interval.Show data: ratios with and without each herbal product
Warfarin clearance and INR ratios with St John's wort, ginkgo and ginger
Herbal product
S-warfarin apparent clearance, ratio (90% CI)
R-warfarin apparent clearance, ratio (90% CI)
INR AUC0–168 h, ratio (90% CI)
St John's wort
1.29 (1.16–1.46)
1.23 (1.11–1.37)
0.79 (0.70–0.95)
Ginkgo
1.05 (0.98–1.21)
1.00 (0.93–1.08)
0.93 (0.81–1.05)
Ginger
1.05 (0.97–1.13)
1.02 (0.95–1.10)
1.01 (0.93–1.15)
Jiang et al. 2004 and 2005, abstracts. None of the four products changed the protein binding or apparent volume of distribution of either warfarin enantiomer, or platelet aggregation.
Documented interactions between supplements and warfarin, with the evidence type
Warfarin and similar anticoagulants antagonize vitamin K; people taking them “need to maintain a consistent intake of vitamin K from food and supplements because sudden changes in vitamin K intakes can increase or decrease the anticoagulant effect”
NIH Office of Dietary Supplements fact sheet, updated October 22, 2026
Associated with inhibiting warfarin's effect and lowering INR, attributed to its vitamin K content
Clinical review (StatPearls, Warfarin Drug Interactions)
NIH ODS, Vitamin K, Fact Sheet for Health Professionals; Jiang X, et al. 2004 and 2005; Yuan CS, et al. Ann Intern Med 2004;141:23–27; Crader MF, Johns T, Arnold JK. Warfarin Drug Interactions. StatPearls, 2023 (herbal products are poorly standardized, which makes interactions hard to demonstrate); Patel S, et al. Warfarin. StatPearls, 2024 (99% protein bound; CYP2C9). Single-dose studies in healthy volunteers do not reproduce long-term therapy in patients.
Lymphatic system
Lymph returns filtered fluid and protein to the veins through one-way vessels and the thoracic duct
Capillaries filter plasma into the tissues and reabsorb most of it. The rest, with protein that leaked out, enters blind-ended lymphatic capillaries and becomes lymph. Collecting vessels with valves carry it through lymph nodes to the thoracic duct and the right lymphatic duct, which empty into the great veins of the neck.
Of 20 liters filtered from capillaries each day, 17 are reabsorbed and 3 return as lymphSchematic, not to scale
Volumes: OpenStax §21.1. Capillary structure, valves and pumping: Ozdowski L, Gupta V. Physiology, Lymphatic System. StatPearls, 2023; Null M, et al. Anatomy, Lymphatic System. StatPearls, 2023. Nodes: ICRP Publication 89, §7.8.1. Thoracic duct and cisterna chyli: Ilahi M, et al. StatPearls, 2023; Null M, et al. StatPearls, 2023.Text version of the drawing
Lymphatic capillariesA single layer of partially overlapping endothelial cells forms button-like openings that let fluid in when the pressure outside is higher; collagen filaments anchor them; they have no valves.
Collecting vesselsOne-way valves prevent backflow; contractile cells pump lymph. At rest this intrinsic pump drives two-thirds of lymph flow; skeletal muscle compression drives the rest.
Lymph nodesFilter lymph; dendritic cells and macrophages inside them trap and destroy many pathogens.
Trunks and cisterna chyliThe thoracic duct runs from the cisterna chyli, a lymph sac at L2 where the lumbar and intestinal lymphatic trunks converge; the intestinal trunk brings chyle. The sac is present in about 40–60% of people; without it the trunks join the duct directly.
Thoracic duct38–45 cm long and 2–5 mm in diameter; drains most of the body except the right upper thorax, the right side of the head and neck and the right arm.
Venous angleIn over 95% of people the duct ends in the internal jugular vein, the subclavian vein or the angle between them; it ends on the right in 2–3%.
Published estimates of lymph flow and lymph node number, which differ between sources
Quantity
Value as stated
Source
Lymph formed per day
3 L (20 L filtered, 17 L reabsorbed)
OpenStax §21.1
Lymphatic fluid and protein transported per day
8 to 12 L
StatPearls, Physiology, Lymphatic System
Thoracic duct output
1.38 mL/kg/hour (about 2.4 L/day for a 73 kg adult, computed)
StatPearls, Thoracic Duct
Number of lymph nodes
At least 600–700; 200–500 in the mesentery
ICRP Publication 89, §7.8.1
Number of lymph nodes
Approximately 450
StatPearls, Physiology, Lymphatic System
The sources do not explain the spread; read these as orders of magnitude. OpenStax gives the left subclavian vein as the thoracic duct's end; StatPearls describes the junction of the subclavian and internal jugular veins and its variants.
Intestinal lymph
Highly lipophilic compounds can travel in chylomicrons through the lymph and skip the liver's first pass
Each intestinal villus usually has one central lymphatic vessel, the lacteal. Portal blood brings the liver everything absorbed from the gut except most of the lipid, which travels in the mesenteric lymph to the thoracic duct. A compound that rides in chylomicrons follows the same path and reaches the systemic veins without first meeting the liver.
Chylomicrons are too large for blood capillaries, so they and the lipophilic compounds they carry leave through the lactealSchematic, not to scale
Trevaskis NL, Charman WN, Porter CJH. Adv Drug Deliv Rev 2008;60:702–716, §2.1 and Fig. 1; Rahmany S, Jialal I. Biochemistry, Chylomicron. StatPearls, 2023 (apoB-48, MTP); Yáñez JA, et al. Adv Drug Deliv Rev 2011;63:923–942 (size); ICRP Publication 89, §6.3 (one lacteal per villus; lipid to the thoracic duct).Text version of the drawing
LumenFatty acid and monoglyceride digestion products are solubilized in the intestinal fluid together with lipophilic compounds.
UptakeThey cross the apical membrane of the enterocytes.
AssemblyIn the endoplasmic reticulum, triglyceride is resynthesized and assembled into lipoproteins; microsomal triglyceride transfer protein (MTP) lipidates apoB-48, one molecule per chylomicron.
ExitChylomicrons (75–1,200 nm) are exocytosed across the basolateral membrane.
LactealTheir size limits diffusion across the blood capillary wall; lymphatic capillaries are significantly more permeable, so lipoproteins and drug associated with them enter the lymph.
Blood capillaryMost absorbed molecules enter the portal blood, whose flow is about 500 times that of intestinal lymph, and reach the liver first.
Factors that govern intestinal lymphatic transport and the evidence behind each
Factor
What the reviews state
Evidence base
Lipophilicity of the compound
Lymph-transported drugs are typically log P > 5
Review criterion after Charman and Stella, 1986; stated as “typically”, not as a strict cutoff
The properties of the lipoprotein, rather than the drug, dictate lymphatic access
Studies of DDT, hydrocarbons and halofantrine in lymph lipoprotein cores
Co-administered lipid: chain length
About 40–60% of a dose of fatty acids with 14 or more carbons reaches the blood through the lymph; shorter, more water-soluble chains go mainly to portal blood
Rat studies
Co-administered lipid: unsaturation
Mono- and polyunsaturated fatty acids give larger lipoproteins and more lymphatic drug transport than saturated ones
Mostly animal studies
Compounds recovered in lymph
Fat-soluble vitamins and derivatives, retinoids, lycopene, probucol, cyclosporine and others; little salicylic acid, isoniazid or caffeine
Mixed species; the retinoid and hydrophilic-drug data are from rats
Measurement in people
“Lymphatic drug transport cannot be studied directly in humans”: lymph duct cannulation is invasive
Rats, dogs, pigs, sheep and rabbits are used instead
Trevaskis NL, Charman WN, Porter CJH. Adv Drug Deliv Rev 2008;60:702–716 (§2.1–2.2, §3); Porter CJH, Trevaskis NL, Charman WN. Nat Rev Drug Discov 2007;6:231–248; Trevaskis NL, Kaminskas LM, Porter CJH. Nat Rev Drug Discov 2015;14:781–803 (lymphatic system in fluid balance, lipid metabolism and immunity; lymph-directed delivery). In greyhound dogs given testosterone undecanoate after food, 83–84% of the systemically available testosterone came from lymph-transported ester; in people, testosterone exposure after this ester rises substantially with food (Trevaskis 2008, §4).
Lymphatic transport is one reason a fat-containing meal or lipid formulation can change exposure to a very lipophilic compound. Formulation approaches are described under Bioavailability design; the gut wall and first pass under ADME, PK and PBPK.
Immune organs
In the ICRP reference man, only 0.2% of the body's lymphocytes are in the blood at any moment; other estimates put it near 2%
Lymphocytes mature in the primary lymphoid organs, bone marrow and thymus, and concentrate in the secondary ones, from which immune responses are launched: lymph nodes, spleen and lymphoid nodules. Most of the adult total of about 1.5 kg sits outside the blood-forming tissues.
Most lymphocytes live in tissues; the spleen, at 150 g, is the largest single mass of lymphatic tissueICRP Publication 89 reference values
ICRP Publication 89 (2002): §7.8.2 (lymphocyte mass and distribution after Osgood 1955; “fixed” lymphatic tissue scaled from Publication 23), §7.8.1 (mesenteric nodes), Table 2.8 and §11.10–11.11 (spleen, thymus, tonsils, active marrow), adult male.Show data: lymphocyte distribution and lymphoid masses, adult male and female
ICRP reference lymphocyte mass and distribution and lymphoid tissue masses
Quantity
Adult male
Adult female
Total lymphocytes, g
1,500
1,300
Distribution: red marrow / blood / spleen, lymph nodes, etc. / outside hematopoietic tissues, %
7.0 / 0.2 / 7.0 / 85.8
7.0 / 0.2 / 7.0 / 85.8
“Fixed” lymphatic tissue, g
730
600
Active (red) marrow, g
1,170
900
Spleen, g
150
130
Thymus, g
25
20
Palatine tonsils (2), g
3
3
Mesenteric lymph nodes, g (ages 20–45)
About 11
Lymphoid organs: type, structure and function
Organ
Type
Structure and function
Red bone marrow
Primary
Site of hematopoiesis; B cells undergo nearly all of their development here
Thymus
Primary
Bilobed organ in the mediastinum where T cells from the marrow mature; 10–15 g at birth, about 30–40 g around puberty, then involution and replacement by fat
Lymph nodes
Secondary
Cortex, paracortex and medulla; filter lymph, and dendritic cells and macrophages remove pathogens
Spleen
Secondary
The only lymphatic organ within the bloodstream; red pulp filters blood and its macrophages recycle iron from old red cells; white pulp mounts T and B cell responses
Peyer's patches (gut-associated lymphoid tissue)
Secondary, mucosa-associated
Oval aggregates of 10–60 nodules, usually 1–4 cm long, mainly in the lower ileum; M (microfold) cells in the overlying epithelium take up particulate antigen; B cells there differentiate into IgA-secreting plasma cells
Tonsils and appendix
Secondary, mucosa-associated
Lymphoid nodules along the pharynx; aggregate nodules are always present in the appendix
OpenStax §21.1; ICRP Publication 89 (2002), §6.3 (lymphatic tissue of the gut), §7 (spleen within the bloodstream), §11.10–11.11; Panneerselvam D, Vaqar S. Peyer Patches. StatPearls, 2023; Kapila V, et al. Physiology, Spleen. StatPearls, 2023; Ozdowski L, Gupta V. StatPearls, 2023 (node structure).
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.
Ready to check what you take?
Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.